Navigation Links
SightMD Announces Strategic Partnership with Mid Island Eye Physicians & Surgeons
Date:10/16/2018

SightMD (or the “Company”), a leading multi-specialty ophthalmology platform and a portfolio company of Chicago Pacific Founders, today announced a strategic partnership with Mid Island Eye Physicians & Surgeons (“Mid Island Eye” or “MIE”). The partnership adds five physicians and one location in Bethpage, NY to SightMD’s team of over 50 physicians and 25 convenient locations in New York.

For more than 50 years, Mid Island Eye has been one of the Nassau County’s preeminent providers of comprehensive ophthalmic care, including laser cataract surgery, glaucoma services, and treatment for conditions affecting the cornea and retina. MIE’s physicians include Jordan Garelick, M.D., Ted Karl, M.D., Laurence Rubin, M.D., and Gregory Cowan, M.D.

“We could not be more thrilled to partner with Mid Island Eye, it’s talented physicians, and staff,” said Jeffrey Martin, M.D., a Founder of SightMD. “I have known Dr. Garelick, Dr. Karl, Dr. Rubin and Dr. Cowan for many years, and believe their clinically excellent practice and patient-first approach align well with SightMD.” John Passarelli, a Founder of SightMD, added, “We look forward to empowering MIE to continue its tradition of serving Nassau County with preeminent eyecare. Our full-service management services organization will enable MIE’s physicians to focus solely on delivering the highest-quality care to the community.”

Dr. Garelick said, “choosing a partner is one of the most critical decisions a practice can make. It was clear from the start of our discussions that the SightMD team knew what it took to take our practice to the next level, while preserving the culture and clinical focus MIE has demonstrated for over 50 years.”

Patients and referring doctors should expect no changes to Mid Island Eye’s providers and locations.

About SightMD
SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 50 ophthalmic surgeons and specialists through the convenience of 25 locations spanning the east end of Long Island to Manhattan. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. SightMD provides its physicians with world-class management services, including a 24/7 call center, billing, credentialing, human resources and other services, enabling them to continue delivering best-in-class care to patients in SightMD’s community. SightMD is backed by Chicago Pacific Founders, a leading middle market private equity firm which focuses exclusively on partnerships with growing companies in the healthcare services sector. For more information about SightMD, please visit http://www.sightmd.com

Read the full story at https://www.prweb.com/releases/sightmd_announces_strategic_partnership_with_mid_island_eye_physicians_surgeons/prweb15840264.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Pharmagen Announces First Quarter 2013 Results
2. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
3. Vasomedical Announces Financial Results for the First Quarter of 2013
4. TSI Announces 2013 Respiratory Protection Roadshow Training Dates and Locations
5. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
6. Active Life Announces $500K Follow On Series A Investment - Tech Coast Angels Re-up
7. Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients
8. DebMed Announces US Patent
9. Physician-Patient Alliance for Health & Safety Announces Four Essentials for Safety for Patients Receiving Opioids
10. Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials
11. OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/10/2019)... (PRWEB) , ... January 10, 2019 , ... ... wellness company providing nutrition and lifestyle solutions, will crown the U.S. winner of ... Period’s 15 finalists include: Andrea Carrara of Palm Beach, Florida; Barbara Lingle of ...
(Date:1/8/2019)... Calif. (PRWEB) , ... January 08, 2019 , ... ... described as a kind of partnership. The implicit terms of this partnership hold ... condition and administer the most effective treatment to restore the patient to improved ...
(Date:1/7/2019)... ... January 07, 2019 , ... A woman’s biological need to wear ... then vaginal health challenges with age or post-partum body form and function changes. What ... social media and public conversations, the world still isn’t talking about real, biological vaginal ...
Breaking Medicine Technology:
(Date:1/14/2019)... ... ... Reviewed & Approved Living Well Providers of 2019. , Acupuncture, Dr. Wai ... - Maplewood , Dr. Joanna Jodar - Somerset , Dr. Barbara Knoll - ... Pleasant , Dr. Robert J. Reinhardt - Pequannock , Dr. Sylvester Rich - ...
(Date:1/13/2019)... , ... , ... to present the following recently reviewed and approved providers for December 2018. , IL Top Docs Include: , ... Dr. Barbara Amsler , Dr. Naresh Chandan , Dr. Marcie Claybon ... Dr. Amarish Dave , OBGYN, Dr. ...
(Date:1/11/2019)... ... 11, 2019 , ... Women’s Excellence Obstetrics and Gynecology announces ... Zaidan, President of Women’s Excellence, will co-host WJR’s "Health Women Show" with WJR’s ... at 7pm. , "We are excited to partner with a longstanding, reputable organization ...
(Date:1/10/2019)... Texas (PRWEB) , ... January 10, 2019 , ... The ... “Zac” Jiwa as its new President & Chief Executive Officer effective immediately. Mr. ... in December after 9 years of service. The transition was announced as part ...
(Date:1/8/2019)... ... January 08, 2019 , ... ... that they now have Norepinephrine in their patent-pending vial-based configuration, Snap-N-Go®, available ... concentrations that are not commercially available) deliver a precise dose when introduced ...
Breaking Medicine News(10 mins):